ESC 365 - Protective effects of renal denervation based on MRI assessment of the brain in patients with resistant hypertension

ESC Premium Access

Protective effects of renal denervation based on MRI assessment of the brain in patients with resistant hypertension

Session: Recent advances in diagnosis/treatment of hypertension

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Speaker: Doctor A. Sukhareva (Tomsk, RU)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Anna Sukhareva

Cardiology Research Institute Tomsk National Research Medical Centre Russian Aca, Tomsk (Russian Federation)

0 follower

3 more presentations in this session

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

Speaker: Doctor P. Kolkhof (Wuppertal, DE)

Potential therapeutic efficacy via avB3-integrin dependent interaction of developmental endothelial locus-1 (Del-1) after established angiotensin-II dependent hypertension

Speaker: Mr M. Amponsah-Offeh (Mannheim, DE)

24-month results and technical approach of catheter-based renal denervation in patients with resistant hypertension

Speaker: Associate Professor D. Maximkin (Moscow, RU)

Access the full session

Recent advances in diagnosis/treatment of hypertension

Speakers: Doctor A. Sukhareva, Doctor P. Kolkhof, Mr M. Amponsah-Offeh, Associate Professor D. Maximkin

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources